Article info

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

Authors

  1. Correspondence to Dr Georgios Sogkas, Rheumatology and Immunology, Hannover Medical School, Hannover, Germany; sogkas.georgios{at}mh-hannover.de
View Full Text

Citation

Adriawan IR, Atschekzei F, Dittrich-Breiholz O, et al
Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

Publication history

  • Received June 9, 2021
  • Accepted September 15, 2021
  • First published September 28, 2021.
Online issue publication 
January 04, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.